NCT00469131View on ClinicalTrials.gov

Effects of Immunosuppression on HCV Recurrence After Living Donor Liver Transplantation - Comparative Study Between Tacrolimus + MMF and Tacrolimus + Steroid

PHASE3CompletedINTERVENTIONAL
Enrollment

79

Participants

Timeline

Start Date

September 30, 2003

Primary Completion Date

August 31, 2010

Study Completion Date

August 31, 2011

Conditions
Hepatitis CLiver Cirrhosis
Interventions
DRUG

tacrolimus + steroid

DRUG

tacrolimus + mycophenolate mofetil

Trial Locations (1)

606-8507

Kyoto University Hospital, Kyoto

All Listed Sponsors
collaborator

Kyoto University

OTHER

lead

Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan

OTHER

NCT00469131 - Effects of Immunosuppression on HCV Recurrence After Living Donor Liver Transplantation - Comparative Study Between Tacrolimus + MMF and Tacrolimus + Steroid | Biotech Hunter | Biotech Hunter